Charles Schwab insider files Form 144 for 13,216-share sale on 08/28/2025
Rhea-AI Filing Summary
The Charles Schwab Corporation (SCHW) Form 144 notifies the planned sale of 13,216 common shares on 08/28/2025 through The Charles Schwab Corporation as broker on the NYSE, with an aggregate market value of $1,309,865.00. The filing states these shares were acquired on 08/28/2025 via various stock option exercises and sales, and payment was completed on that date. The filer previously sold 3,296 shares on 08/27/2025 for $320,305.00. Outstanding shares are listed as 1,815,219,300, showing the planned sale represents a de minimis fraction of total shares.
Positive
- Clear disclosure of the proposed sale, including exact share counts, dates, broker, and aggregate market value
- Compliance with Rule 144 requirements by reporting acquisition method (stock option exercise) and prior three-month sale
- Transaction size is de minimis relative to the reported 1,815,219,300 shares outstanding (approximately 0.00073%)
Negative
- None.
Insights
TL;DR: Form 144 discloses an insider sale following option exercises; it fulfills Rule 144 notice requirements and shows transparency.
The filing documents a proposed sale of 13,216 common shares on 08/28/2025, acquired the same day through stock option exercises and sales, with the broker listed as The Charles Schwab Corporation and execution on the NYSE. The notice also reports a recent sale of 3,296 shares on 08/27/2025 for $320,305.00. From a compliance perspective, the form provides required details about acquisition, sale dates, amounts, and broker, supporting adherence to Rule 144 disclosure obligations.
TL;DR: The disclosed sale is immaterial relative to outstanding shares and unlikely to affect market supply materially.
With 1,815,219,300 shares outstanding, the 13,216-share proposed sale equals roughly 0.00073% of the float (calculated from the provided figures). The aggregate value reported is $1,309,865.00. Such small, scheduled insider sales after option exercises are routine and generally not market-moving. The filing's specificity—dates, amounts, broker, and prior three-month sale—aligns with market transparency expectations.